NHS England statement on Alzheimer’s treatment lecanemab: Thursday 22 August 2024
In response to the MHRA and NICE decisions on lecanemab, Professor Sir Stephen Powis, NHS National Medical Director, said: “The NHS now awaits a final decision from the National Institute for Health and Care Excellence that will look at the clinical …